Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Red Arrow Therapeutics
Tokyo, Japan
A
1-10 Employees
2021
Key takeaway
Red Arrow Therapeutic is a biotech startup that is developing an innovative drug delivery system using nanotechnology, which is directly related to the field of nanomedicine.
Reference
Core business
HOME | Red Arrow Theraputic
Libra Medicina
Sapporo, Japan
A
1-10 Employees
2009
Key takeaway
LibraMedicina Ltd. focuses on creating new medicines and medical devices, with a particular emphasis on improving health and quality of life for patients. Their expertise includes contract research and development for biopharmaceuticals and synthetic drugs, especially in the field of cancer.
Reference
Service
Consulting for pharmaceutical development, functional food development - リブラメディシーナ
Consulting for pharmaceutical development We provide support services for designing and implementing development plans related to preclinical and clinical research. Especially in the field of cancer, we have strong ties with leading clinical research institutes which have a wealth of knowledge and experience in clinical trials. Consulting for functional food development We have extensive experience in development planning, preclinical evaluation, and clinical trials for functional foods in various fields, and will support your development. For more information, please contact us.
T Cell Nouveau
Tokyo, Japan
A
1-10 Employees
2021
Key takeaway
The company, T Cell Nouveau Inc., is advancing nanomedicine through its innovative Hybrid CAR T-cell therapy, which aims to enhance the immune system's ability to target and treat solid tumors that are resistant to traditional CAR and TCR-T cell therapies. Their patented TCR-like CAR antibody technology demonstrates high specificity for certain cancer antigens, offering a promising approach to cancer immunotherapy.
Reference
Core business
Car-t細胞療法 | T Cell Nouveau、ティーセルヌーヴォー株式会社 | 東京都
ティーセルヌーヴォー株式会社は臨床段階のバイオメディカル企業であり、三重大学 珠玖研究室が開発した最先端のTCR like CAR-T細胞療法を用いて、免疫系を賦活化することにより固形がんを治療することを目指しています。私たちのユニークなTCR like CAR T細胞療法は、近年のCAR-T細胞療法あるいはTCR-T細胞療法が奏功しない固形がんの治療を目指す飛躍的な革新技術であると強く信じています。私たちの特許技術であるTCR like CAR抗体は、ペプチド-HMC複合体における標的抗原（MAGE4またはPRAME）に対して高い特異性を有しています。さらに、私たちの特許技術であるシグナルドメイン構造は、免疫抑制性のがん微小環境において、T cell機能の活性化、維持及び持続を助けます。
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
AceRNA
Kyoto, Japan
A
1-10 Employees
2018
Key takeaway
The company is a biotech startup dedicated to creating innovative genetic therapies that specifically target disease-causing cells, aiming to minimize patient burden. They are focused on developing groundbreaking treatments using RNA Switches, which could have significant implications for targeted medicine.
Reference
Core business
News - aceRNA
aceRNA
GeneFrontier Japan
Sakai, Japan
A
- Employees
2010
Key takeaway
The company specializes in protein engineering and biologics, highlighting its innovative approaches to developing novel biopharmaceuticals and drug discovery.
Reference
Product
Drug Discovery | 日本語版
Beyond Next Ventures
Tokyo, Japan
A
1-10 Employees
2014
Key takeaway
The company, Beyond Next Ventures, is dedicated to supporting researchers and entrepreneurs in the deep tech sector, including drug discovery and biotech. Their resources encompass business planning, financial assistance, and access to incubation facilities, all aimed at fostering innovations that can address global challenges.
Reference
Product
Drug discovery / Biotech | Beyond Next Ventures
001
Medmain
Fukuoka, Japan
A
11-50 Employees
2018
Key takeaway
Medmain is revolutionizing pathology through its PidPort system, which utilizes Deep Learning and AI for precise and rapid pathological image diagnosis. This innovation aligns with the growing field of nanomedicine by enhancing diagnostic capabilities and enabling remote access to medical services.
Reference
Core business
Medmain inc.
To create a world where medical services can be accessed with technology anywhere,anytime-As a supporting partner to medical practitioners throughout the world, Medmain develops and operates PidPort, an analytical system for pathological image diagnosis that makes use of Deep Learning, as well as Medteria, a specialized cloud-based service for medical students.
AccuRna
Tokyo, Japan
A
1-10 Employees
2015
Key takeaway
AccuRna is focused on developing innovative drug delivery systems for nucleic acid therapeutics, including ASO, siRNA, miRNA, and mRNA, which are crucial in the field of nanomedicine. Their mission is to provide effective treatments for patients with refractory diseases through advanced nucleic acid-based therapies.
Reference
Product
Technologies – AccuRna, Inc.
Luxna Biotech
Japan
A
1-10 Employees
2017
Key takeaway
Luxna Biotech is focused on developing oligonucleotide therapeutics, which are a key area in nanomedicine. Their commitment to advancing modified nucleic acids (XNA) aims to provide innovative treatments for diseases that currently lack effective drug options.
Reference
Core business
Luxna Biotech Co., Ltd.
D3
Tokyo, Japan
A
- Employees
-
Key takeaway
The company, McKinsey, emphasizes its expertise in the discovery, development, and deployment of innovative solutions for global health, integrating scientific knowledge with business acumen.
Reference
Core business
D3 LLC
DISCOVERY, DEVELOPMENT, DEPLOYMENT FOR GLOBAL HEALTH, WITH SCIENCE & BUSINESS ACUMEN
Technologies which have been searched by others and may be interesting for you:
When exploring the nanomedicine industry in Japan, several key considerations are essential. The regulatory environment is a significant factor, as Japan has stringent guidelines governed by the Pharmaceuticals and Medical Devices Agency (PMDA), which oversee the approval of nanomedicine products. Companies must navigate these regulations carefully to ensure compliance. Challenges include the high costs of research and development, potential safety concerns regarding nanomaterials, and the need for specialized expertise in nanotechnology. On the opportunities front, Japan boasts a strong research infrastructure and a growing demand for innovative healthcare solutions, particularly in aging populations. Collaborations between universities, research institutions, and private companies are fostering advancements in the field. The competitive landscape features both established pharmaceutical companies and dynamic startups, driving innovation and market growth. Environmental concerns are also pertinent, as the production and disposal of nanomaterials can pose ecological risks. Companies must adopt sustainable practices to mitigate these effects. Finally, Japan's position in the global nanomedicine market is critical, as it serves as a hub for research and development in Asia, with potential partnerships and collaborations extending to international markets. Understanding these factors will provide a comprehensive overview for anyone interested in the nanomedicine sector in Japan.
Some interesting numbers and facts about your company results for Nanomedicine
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 32 |
| Amount of suitable service providers | 23 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2009 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Nanomedicine
What are related technologies to Nanomedicine?
Based on our calculations related technologies to Nanomedicine are Glass, Superconductors, High-Performance Materials, Raw Materials, Phase Change Materials
Who are Start-Ups in the field of Nanomedicine?
Start-Ups who are working in Nanomedicine are Red Arrow Therapeutics, T Cell Nouveau
Which industries are mostly working on Nanomedicine?
The most represented industries which are working in Nanomedicine are Other, Biotechnology, Medical, IT, Software and Services, Healthcare
How does ensun find these Nanomedicine Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.